J. Safra Sarasin Holding’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$73.1M Sell
207,680
-38,033
-15% -$13.6M 1.25% 19
2025
Q4
$80.4M Sell
245,713
-1,415
-0.6% -$449K 1.31% 17
2025
Q3
$69.7M Buy
247,128
+6,833
+3% +$1.98M 1.13% 22
2025
Q2
$67.1M Sell
240,295
-6,060
-2% -$1.72M 1.16% 24
2025
Q1
$76.8M Buy
246,355
+1,478
+0.6% +$436K 1.39% 17
2024
Q4
$63.8M Sell
244,877
-26,882
-10% -$7.98M 1.08% 28
2024
Q3
$87.6M Buy
271,759
+3,236
+1% +$1.06M 1.52% 13
2024
Q2
$83.9M Buy
+268,523
New +$78.9M 1.53% 9

Other funds holding AMGN

J. Safra Sarasin Holding's AMGN Position: Q1 2026 in Review

J. Safra Sarasin Holding reduced its Amgen (AMGN) stake by 15% in Q1 2026, selling an estimated $13.6M and leaving 207,680 shares worth $73.1M. The position accounts for 1.25% of the portfolio, ranked #19.

J. Safra Sarasin Holding first reported a position in AMGN in Q2 2024 and has held it in 8 quarters since. The position peaked at $87.6M in Q3 2024. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • J. Safra Sarasin Holding held 207,680 shares of Amgen worth $73.1M as of Q1 2026.
  • J. Safra Sarasin Holding sold 38,033 Amgen shares in Q1 2026, an estimated $13.6M.
  • Amgen made up 1.25% of J. Safra Sarasin Holding's portfolio in Q1 2026, its #19 holding.
  • J. Safra Sarasin Holding first reported a position in Amgen in Q2 2024 and has held it in 8 quarters since.
  • J. Safra Sarasin Holding's Amgen position peaked at $87.6M in Q3 2024.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on J. Safra Sarasin Holding's 13F filing for Q1 2026, filed 4 May 2026.